Canada markets closed

Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
8.74-0.05 (-0.57%)
At close: 03:00PM CST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
4,197,210
4,578,746
12,951,443
12,363,271
13,615,482
Cost of Revenue
2,117,036
2,450,211
9,759,166
9,187,245
10,847,095
Gross Profit
2,080,174
2,128,536
3,192,277
3,176,026
2,768,387
Operating Expenses
Research Development
156,379
153,365
133,917
118,752
77,166
Selling General and Administrative
1,485,606
1,505,145
1,406,792
1,361,351
930,650
Total Operating Expenses
1,811,535
1,820,043
2,310,671
2,312,168
1,969,785
Operating Income or Loss
268,640
308,493
881,606
863,858
798,602
Interest Expense
41,630
93,774
400,119
111,753
91,204
Income Before Tax
326,623
412,963
261,058
643,731
853,503
Income Tax Expense
41,496
46,823
195,960
249,933
214,614
Income from Continuing Operations
285,127
366,140
65,098
393,798
638,889
Net Income
233,091
303,387
45,455
361,901
638,669
Net Income available to common shareholders
233,091
303,387
45,455
361,901
638,669
Basic EPS
0.12
0.30
0.04
0.36
0.64
Diluted EPS
0.12
0.30
0.04
0.35
0.63
Basic Average Shares
1,143,706
1,011,291
1,136,384
1,005,280
997,921
Diluted Average Shares
1,143,706
1,011,291
1,136,384
1,034,003
1,013,761